Floatz logo

Cyclophosphamide

Anal Carcinoma

Christian HinrichsSmall moleculePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
73/ 100

Competitive context

45 Active assets in the Anal Carcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Federation Francophone de Cancerologie Digestive
Phase 3BB
Carboplatin
Dustin Deming
Phase 3BB
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 3BB
Irinotecan
University of Cincinnati
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Federation Francophone de Cancerologie Digestive
Phase 3BB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →